跳转至内容
Merck
所有图片(1)

主要文件

SML0719

Sigma-Aldrich

恩氯米芬 盐酸盐

≥96% (HPLC)

别名:

(E)-克罗米芬 盐酸盐, 2- [4-\ [(1E)-2-氯-1,2-二苯乙烯基] 苯氧基]-N,N-二乙基-乙胺 盐酸盐, 2- [对-(2-氯-反式-1,2-二苯基乙烯基)苯氧基] 三乙胺 盐酸盐, ICI 46476, 反式氯米芬 盐酸盐

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C26H28ClNO · HCl
CAS号:
分子量:
442.42
分類程式碼代碼:
51111800
NACRES:
NA.77

品質等級

化驗

≥96% (HPLC)

形狀

powder

儲存條件

protect from light

顏色

white to beige

溶解度

H2O: 10 mg/mL, clear

儲存溫度

2-8°C

SMILES 字串

Cl\C(=C(\c3ccc(cc3)OCCN(CC)CC)/c2ccccc2)\c1ccccc1.Cl

InChI

1S/C26H28ClNO.ClH/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23;/h5-18H,3-4,19-20H2,1-2H3;1H/b26-25+;

InChI 密鑰

KKBZGZWPJGOGJF-BTKVJIOYSA-N

生化/生理作用

顺式克罗米酚是一种非甾体雌激素受体拮抗剂,可促进睾丸分泌促性腺激素依赖性睾酮。
顺式克罗米酚是一种非甾体雌激素受体拮抗剂,可促进睾丸分泌促性腺激素依赖性睾酮。顺式克罗米酚是克罗米芬的反式异构体,约为反式(顺式克罗米酚)和顺式(逆式克罗米酚)的 60-40 混合物。顺式克罗米酚(反式克罗米酚)是一种雌激素拮抗剂,而逆式克罗米酚(顺式克罗米酚)是一种混合激动剂,具有雌激素活性,因此常见的副作用有时见于男性。顺式克罗米酚异构体负责抗雌激素活性和下丘脑-垂体-性腺轴的恢复。在最近的临床试验中,顺式克罗米酚使继发性性腺机能减退男性的血清 LH 和 FSH 升高,同时睾酮升高。顺式克罗米酚表现出总体上优于睾酮凝胶的效果,睾酮凝胶可升高血清睾酮,但同时可降低 LH 和 FSH。

其他說明

光敏感

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

A Ayaz et al.
Journal of medicine and life, 6(2), 199-201 (2013-08-02)
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women and is associated with the reproductive and metabolic disorders. To compare the ovulation and conception rates after the treatment with Clomiphene Citrate (CC) alone and in combination with metformin
Serkan Yilmaz et al.
Mutation research. Genetic toxicology and environmental mutagenesis, 759, 21-27 (2013-11-06)
Clomiphene citrate (CC) is a selective estrogen-receptor modulator that is primarily used to enhance follicular development in women receiving in vitro fertilization (IVF) treatment. Although some studies suggested large increases in ovarian cancer risk related to fertility medications, this association
Marleen J Nahuis et al.
BMC women's health, 13, 42-42 (2013-10-29)
Clomiphene citrate (CC) is first line treatment in women with World Health Organization (WHO) type II anovulation and polycystic ovary syndrome (PCOS). Whereas 60% to 85% of these women will ovulate on CC, only about one half will have conceived
Fertility and sterility, 100(2), 341-348 (2013-07-03)
This committee opinion describes the use of clomiphene citrate, including indications, use, monitoring, and side effects. There is also a discussion of adjuvants and alternatives to clomiphene citrate therapy.
Akmal El-Mazny et al.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 29(9), 826-829 (2013-07-17)
To evaluate the ability of a combination of multiple ovarian reserve markers to predict ovarian stimulation response in polycystic ovary syndrome (PCOS). On cycle Day 3 of 75 infertile patients with PCOS, serum follicle stimulating hormone (FSH), luteinizing hormone (LH)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门